Portfolio Company Job Board

Find a job at one of our innovative portfolio companies
Sands Capital
companies
Jobs
Inspirna, Inc.(formerly Rgenix, Inc.)
Inspirna, Inc.(formerly Rgenix, Inc.)
inspirna.com

Locations

New York, NY, USA

industry

Biotechnology

Size

11-50 employees

Stage

Series C+

founded in

2010

Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need. Inspirna’s lead drug candidate, Ompenaclid (RGX-202), is an orally-administered small molecule that targets the CKB/SLC6A8 pathway, which when activated enables the generation of ATP in response to tumor hypoxia. Ompenaclid is currently being tested in multiple mid-stage clinical trials in patients with advanced or metastatic RAS mutant colorectal cancer. Inspirna’s second clinical stage drug candidate, Abequolixron (RGX-104), is an oral small molecule activator of LXR/APOE that inhibits angiogenesis and tumor myeloid derived suppressor cells to enhance the immune response against tumors. Abequolixron is currently being tested in a Phase 1b/2 clinical trial in patients with advanced or metastatic lung cancer in combination with docetaxel and endometrial cancer in combination with ipilimumab.

Something looks off?
Open jobs at Inspirna, Inc.(formerly Rgenix, Inc.)
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.